Carcinogenesis, Vol. 20, No. 8, 1439-1444,
August 1999
© 1999 Oxford University Press
Cancer Biology |
PolyADP-ribose-mediated regulation of p53 complexed with topoisomerase I following ionizing radiation
Environmental Toxicology Program, University of California, 5419 Boyce Hall, Riverside, CA 92521, USA
This investigation demonstrates that the p53 and topoisomerase I (topo I) proteins which form a molecular complex in vivo are polyADP ribosylated following 1 Gy of
irradiation. Immunoprecipitations using a topo I monoclonal antibody were performed on protein extracts from
-irradiated TK6 human lymphoblastoid cells. Western blots on topo I immunoprecipitations probed with a polyADP-ribose polymer antibody demonstrated that several proteins, including p53, are co-immunoprecipitated with topo I. Furthermore, p53 and topo I are ADP ribosylated within 15 min following
irradiation. Unlike the other proteins within the complex, p53 is polyADP ribosylated at low levels in non-irradiated cells, and it is also the most heavily polyADP ribosylated following irradiation. Radiation induced polyADP ribosylation persists for at least 48 h following exposure. The DNA damage response does not involve the recruitment of free p53 to complex with topo I; the amount of p53 protein complexed with topo I was found to be independent of radiation exposure. It has recently been reported that p53 acts to catalytically stimulate the activity of topo I in the absence of DNA damage. We hypothesize that the rapid modification of the complex by polyADP ribosylation following radiation is a regulatory response to diminish topo I cleavage in the presence of DNA damage.
Abbreviations: PARP, polyADP-ribose polymerase; topo I, topoisomerase I
1 To whom correspondence should be addressed Email: grosovsky{at}ucr.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. O. Hassa, S. S. Haenni, M. Elser, and M. O. Hottiger Nuclear ADP-Ribosylation Reactions in Mammalian Cells: Where Are We Today and Where Are We Going? Microbiol. Mol. Biol. Rev., September 1, 2006; 70(3): 789 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Pond, K. M. Marshall, and L. R. Barrows Identification of a small topoisomerase I-binding peptide that has synergistic antitumor activity with 9-aminocamptothecin. Mol. Cancer Ther., March 1, 2006; 5(3): 739 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ishizuka, K. Martin, C. Booth, C. S. Potten, G. de Murcia, A. Burkle, and T. B. L. Kirkwood Poly(ADP-ribose) polymerase-1 is a survival factor for radiation-exposed intestinal epithelial stem cells in vivo Nucleic Acids Res., November 1, 2003; 31(21): 6198 - 6205. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Jones, J. McIntosh, H. Huang, A. Graytock, and D. G. Hoyt Regulation of Bleomycin-Induced DNA Breakage and Chromatin Structure in Lung Endothelial Cells by Integrins and Poly(ADP-Ribose) Polymerase Mol. Pharmacol., January 1, 2001; 59(1): 69 - 75. [Abstract] [Full Text] |
||||



